HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Choseido Suspended from JGA for 5 Years after Biz Suspension Order
October 15, 2021
-
ORGANIZATION EFPIA to Ponder Position on Macroeconomic Indexing with Patient Access as Top Priority, Continue Dialogue with Japan Govt
October 14, 2021
-
COMMENTARY Pharma on Alert for Possible Repeat of Minister Deal on Drug Pricing Reform
October 13, 2021
-
BUSINESS Japan Drug Makers Prepping to Launch New Organization to Solve Challenges in Digital Health
October 13, 2021
-
REGULATORY Choseido Woes Cast Clouds on Generic Inroads in Tokushima, Worst Player in Penetration
October 12, 2021
-
BUSINESS Chugai Seeks Japan Nod for Ronapreve in Prophylaxis, Asymptomatic COVID-19
October 12, 2021
-
BUSINESS Ivermectin COVID-19 Trial Needed Because Evidence Is Lacking, Kowa Says as It Aims for PIII Wrap-Up in November
October 11, 2021
-
REGULATORY MHLW Orders Large-Scale Carcinogen Risk Inspections, Covering Almost All Drugs
October 11, 2021
-
REGULATORY Choseido Hit by Biz Suspension of Up to 31 Days over Manufacturing Flaws
October 11, 2021
-
REGULATORY Japan Clinches Deal for 120 Million Extra Pfizer Vaccine Doses
October 8, 2021
-
BUSINESS Licensing Izcargo to Takeda First Step to Expanded Application of JCR’s BBB-Penetrating Technology: Chairman
October 8, 2021
-
ORGANIZATION JMA Exec Chides Pharma for Requesting Price Measure to Ensure Stable Supplies, Says Compliance System Should Come First
October 7, 2021
-
BUSINESS Takeda Suspends PII Trials of Narcolepsy Drug Hopeful on Safety Concerns
October 7, 2021
-
BUSINESS Oncolys Aims to Bring Nucleocapsid Inhibitor into Clinic Next Year for COVID-19 Treatment
October 6, 2021
-
REGULATORY Transparency and Predictability Up for Discussion towards 2022 Drug Pricing Reform: New Minister
October 6, 2021
-
REGULATORY New Health Minister Goto Vows to Protect Secure Healthcare System in FY2022 Reform
October 5, 2021
-
REGULATORY No Factor to Impede Reinstatement of HPV Vaccine Recommendation: Panels
October 4, 2021
-
ORGANIZATION FPMAJ to Define Shipment Situation in Preparation for Supply Information Centralization
October 1, 2021
-
BUSINESS Sumitomo Dainippon, Otsuka Ink Global Collaboration for 4 Neuropsychiatric Drugs
October 1, 2021
-
REGULATORY Pharma Officials Air Hopes and Concerns for New LDP Leader, Eyes on MHLW Revamp
September 30, 2021
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
